RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 121 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,326,376 | -16.3% | 1,228,126 | 0.0% | 0.24% | -2.0% |
| Q2 2023 | $1,584,283 | -36.1% | 1,228,126 | -34.6% | 0.25% | -40.3% |
| Q1 2023 | $2,480,075 | -27.4% | 1,878,845 | -17.6% | 0.41% | -43.6% |
| Q4 2022 | $3,418,268 | +33.9% | 2,278,845 | +5.4% | 0.73% | +107.3% |
| Q3 2022 | $2,552,000 | -10.6% | 2,162,586 | -14.4% | 0.35% | +16.1% |
| Q2 2022 | $2,853,000 | +336.9% | 2,525,000 | +1002.1% | 0.30% | +67.6% |
| Q4 2013 | $653,000 | – | 229,100 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 4,500,000 | $11,925,000 | 4.90% |
| HealthInvest Partners AB | 1,090,000 | $2,889,000 | 4.07% |
| GREAT POINT PARTNERS LLC | 5,000,000 | $13,250,000 | 2.94% |
| CM Management, LLC | 775,000 | $2,054,000 | 1.55% |
| SECTOR GAMMA AS | 1,469,604 | $3,894,000 | 0.92% |
| Sio Capital Management, LLC | 913,621 | $2,421,000 | 0.73% |
| Telemetry Investments, L.L.C. | 190,000 | $504,000 | 0.65% |
| DAFNA Capital Management LLC | 879,000 | $2,329,000 | 0.59% |
| Rock Springs Capital Management LP | 4,860,200 | $12,880,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $4,074,000 | 0.27% |